Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest press releases The press releases are intended for media and financial analysts Press release 9 Nov 2026 ACR 2026: Dapirolizumab Pegol Associated with Greater Treatment Response Rates Versus Placebo in SLE... Read More Press release 9 Nov 2026 BE BOLD: BIMZELX[®] (bimekizumab-bkzx) builds on superior joint responses versus SKYRIZI[®]... Read More Press release 4 Nov 2026 UCB advances its digital antibody engineering program with new Cradle collaboration Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Press release 9 Nov 2026 ACR 2026: Dapirolizumab Pegol Associated with Greater Treatment Response Rates Versus Placebo in SLE... Read More
Press release 9 Nov 2026 BE BOLD: BIMZELX[®] (bimekizumab-bkzx) builds on superior joint responses versus SKYRIZI[®]... Read More
Press release 4 Nov 2026 UCB advances its digital antibody engineering program with new Cradle collaboration Read More
